Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ZIOPHARM Oncology Inc Prices Public Offering Of Common Stock

Thursday, 24 Oct 2013 07:00am EDT 

ZIOPHARM Oncology Inc announced the pricing of its previously announced public offering of 14,300,000 shares of its common stock at a public offering price of $3.50 per share. All of the shares in the offering are being sold by ZIOPHARM. The offering is expected to close on October 29, 2013, subject to customary closing conditions. J.P. Morgan Securities LLC is acting as sole book-running manager for the offering. JMP Securities LLC and Griffin Securities, Inc. are acting as co-managers. ZIOPHARM has granted the underwriters a 30-day option to purchase up to an additional 2,145,000 shares. ZIOPHARM intends to use the net proceeds from the public offering for the overall development of its drug candidates, including its synthetic biology candidates and small molecule candidates, and for general corporate and working capital purposes. 

Company Quote

0.19 +4.65%
26 Nov 2014